These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35691981)

  • 21. Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells.
    Wu D; Tao J; Xu B; Qing W; Li P; Lu Q; Zhang W
    Urol Int; 2011; 86(3):346-54. PubMed ID: 21273759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tannic Acid Impedes the Proliferation of Bladder Cancer Cells by Elevating Mitochondrial Pathways of Apoptosis.
    Li CC; Tsai BC; Annseles Rajula S; Hsu CH; Chen MC; Kuo CH; Yeh CM; Hsieh DJ; Kuo WW; Huang CY
    Cell Biochem Biophys; 2024 May; ():. PubMed ID: 38809348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression.
    Zhao B; Li X
    Oncol Rep; 2014 Jun; 31(6):2769-75. PubMed ID: 24700345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursolic acid induces apoptosis via Akt/NF-κB signaling suppression in T24 human bladder cancer cells.
    Gai L; Cai N; Wang L; Xu X; Kong X
    Mol Med Rep; 2013 May; 7(5):1673-7. PubMed ID: 23483134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
    Dong Q; Fu L; Zhao Y; Tan S; Wang E
    Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
    Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
    Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of apoptosis through inactivation of ROS-dependent PI3K/Akt signaling pathway by platycodin D in human bladder urothelial carcinoma cells.
    Park C; Cha HJ; Lee H; Jeong JW; Han M; Song KS; Kim GY; Chang YC; Leem SH; Hyun JW; Kim HS; Hong SH; Choi YH
    Gen Physiol Biophys; 2022 Jul; 41(4):263-274. PubMed ID: 35938960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oleanolic acid suppresses the proliferation of human bladder cancer by Akt/mTOR/S6K and ERK1/2 signaling.
    Mu DW; Guo HQ; Zhou GB; Li JY; Su B
    Int J Clin Exp Pathol; 2015; 8(11):13864-70. PubMed ID: 26823699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resveratrol induces apoptosis of bladder cancer cells via miR‑21 regulation of the Akt/Bcl‑2 signaling pathway.
    Zhou C; Ding J; Wu Y
    Mol Med Rep; 2014 Apr; 9(4):1467-73. PubMed ID: 24535223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for Akt in the rapid regulation of inflammatory and apoptotic pathways in mouse bladder.
    Tamarkin FJ; Kang WS; Cohen JJ; Wheeler MA; Weiss RM
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Aug; 373(5):349-59. PubMed ID: 16832691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism.
    Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S
    Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tormentic acid inhibits IL-1β-induced chondrocyte apoptosis by activating the PI3K/Akt signaling pathway.
    Yang Y; Wang Y; Zhao M; Jia H; Li B; Xing D
    Mol Med Rep; 2018 Mar; 17(3):4753-4758. PubMed ID: 29328385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo.
    Sun F; Zheng XY; Ye J; Wu TT; Wang Jl; Chen W
    Nutr Cancer; 2012; 64(4):599-606. PubMed ID: 22482362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells.
    Li HL; Zhang S; Wang Y; Liang RR; Li J; An P; Wang ZM; Yang J; Li ZF
    Mol Med Rep; 2013 Jan; 7(1):266-70. PubMed ID: 23064738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfated polysaccharide of
    Shan L; Liu W; Zhan Y
    Aging (Albany NY); 2019 Sep; 11(18):7780-7795. PubMed ID: 31545294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
    Jia X; Wen Z; Sun Q; Zhao X; Yang H; Shi X; Xin T
    J BUON; 2019; 24(5):1985-1991. PubMed ID: 31786865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tormentic acid inhibits hepatic stellate cells activation via blocking PI3K/Akt/mTOR and NF-κB signalling pathways.
    Lin X; Li Y; Zhang X; Wei Y; Wen S; Lu Z; Huang Q; Wei J
    Cell Biochem Funct; 2021 Jan; 39(1):77-87. PubMed ID: 32564421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk.
    Peng M; Huang Y; Tao T; Peng CY; Su Q; Xu W; Darko KO; Tao X; Yang X
    Sci Rep; 2016 Jun; 6():28611. PubMed ID: 27334428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
    Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
    Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.